MELA Sciences to Report Third Quarter Financial Results on Thursday, November 12

HORSHAM, Pa., Oct. 29, 2015 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (NASDAQ:MELA), a medical technology company dedicated to developing and commercializing innovative products for the diagnosis and treatment of serious dermatological disorders, will release third quarter financial results on Thursday, November 12, after the market close. MELA Sciences President and Chief Executive Officer, Michael Stewart, and Robert Cook, Chief Financial Officer, will host a conference call at 4:30pm Eastern Time to review the Company's progress and answer questions.

Conference Call Details:
Date:Thursday, November 12
Time:4:30pm Eastern Time
Toll Free:888-430-8691
International:719-325-2376
Passcode:714691
Webcast:www.melasciences.com
  
Replays, available through November 26, 2015
Toll Free:877-870-5176
International:858-384-5517
Replay PIN:714691

About MELA Sciences, Inc.  (www.melasciences.com

MELA Sciences is a medical technology company focused in the dermatology market. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; and the MelaFind System used to assist in the identification and management of melanoma skin cancer.

CONTACT: Investor Contacts:
         Robert W. Cook
         MELA Sciences, Inc.
         914 373 6936
         rcook@melasciences.com
         
         Andrew McDonald
         LifeSci Advisors, LLC
         646-597-6987
         Andrew@LifeSciAdvisors.com

Ads